DE602005017877D1 - Restenose-therapie mit mesenchym-stammzellen - Google Patents

Restenose-therapie mit mesenchym-stammzellen

Info

Publication number
DE602005017877D1
DE602005017877D1 DE602005017877T DE602005017877T DE602005017877D1 DE 602005017877 D1 DE602005017877 D1 DE 602005017877D1 DE 602005017877 T DE602005017877 T DE 602005017877T DE 602005017877 T DE602005017877 T DE 602005017877T DE 602005017877 D1 DE602005017877 D1 DE 602005017877D1
Authority
DE
Germany
Prior art keywords
mesencym
stem cells
restenosis therapy
restenosis
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005017877T
Other languages
English (en)
Inventor
Toby Freyman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Boston Scientific Ltd Barbados
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Ltd Barbados filed Critical Boston Scientific Ltd Barbados
Publication of DE602005017877D1 publication Critical patent/DE602005017877D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
DE602005017877T 2004-03-30 2005-03-29 Restenose-therapie mit mesenchym-stammzellen Active DE602005017877D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55738804P 2004-03-30 2004-03-30
PCT/US2005/010146 WO2005097147A1 (en) 2004-03-30 2005-03-29 Restenosis therapy using mesenchymal stem cells

Publications (1)

Publication Number Publication Date
DE602005017877D1 true DE602005017877D1 (de) 2010-01-07

Family

ID=34963883

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017877T Active DE602005017877D1 (de) 2004-03-30 2005-03-29 Restenose-therapie mit mesenchym-stammzellen

Country Status (4)

Country Link
US (2) US20050233443A1 (de)
EP (1) EP1729788B1 (de)
DE (1) DE602005017877D1 (de)
WO (1) WO2005097147A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004069172A2 (en) 2003-01-30 2004-08-19 The Government of the United States of America as represented by the Department of Veterans Affairs Multilineage-inducible cells and uses thereof
US7603154B2 (en) * 2003-04-24 2009-10-13 Koninklijke Philips Electronics N.V. Non-invasive left ventricular volume determination
US7326571B2 (en) * 2003-07-17 2008-02-05 Boston Scientific Scimed, Inc. Decellularized bone marrow extracellular matrix
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
KR101209833B1 (ko) 2004-06-17 2012-12-07 메사추세츠 인스티튜트 오브 테크놀로지 핵 형태에 기초하여 줄기 세포를 동정하는 방법
EP1790350A1 (de) * 2005-11-24 2007-05-30 Interstitial Therapeutics Verwendung einer Keratinozytzusammensetzung für die Behandlung von Restenosis
US20070178137A1 (en) * 2006-02-01 2007-08-02 Toby Freyman Local control of inflammation
BRPI0811906A2 (pt) * 2007-05-24 2014-11-18 Apceth Gmbh & Co Kg Composições e métodos relacionados a célula-tronco cd34
US8685728B2 (en) 2008-01-31 2014-04-01 Rutgers The State University Of New Jersey Kit containing stem cells and cytokines for use in attenuating immune responses
US10046011B2 (en) 2008-01-31 2018-08-14 Rutgers, The State University Of New Jersey Compositions for inducing or suppressing an immune response
EP2344880B1 (de) 2008-09-24 2015-08-19 Massachusetts Institute of Technology Verfahren zur identifizierung von stammzellen durch fluoreszenznachweis von zellen und synzytien
WO2011047277A2 (en) 2009-10-15 2011-04-21 The Brigham And Women's Hospital, Inc. Release of agents from cells
JP2013540276A (ja) * 2010-10-25 2013-10-31 マサチューセッツ インスティテュート オブ テクノロジー 創傷を治癒するメタカリオート（ｍｅｔａｋａｒｙｏｔｉｃ）幹細胞、およびその使用方法
US20140154274A1 (en) * 2011-01-12 2014-06-05 Tigenix Nv Methods and compositions for use in intralymphatic cellular therapies
CA3129372A1 (en) * 2019-02-07 2020-08-13 Sapporo Medical University Pharmaceutical composition for preventing in-stent restenosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811094A (en) * 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
CA2296704C (en) * 1997-07-14 2010-10-19 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US6458590B1 (en) * 1997-08-07 2002-10-01 The United States Of America, As Represented By The Department Of Health And Human Services Methods and compositions for treatment of restenosis
US6140127A (en) * 1998-02-18 2000-10-31 Cordis Corporation Method of coating an intravascular stent with an endothelial cell adhesive five amino acid peptide
BR9912662A (pt) * 1998-07-31 2001-06-05 Genzyme Corp Melhoria de função cardìaca por transplante de célula de ramo mesenquimal
JP2005531507A (ja) * 2002-03-02 2005-10-20 ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム ストローマ細胞前駆体による抗癌物質の局所的な産生および／または送達方法
US20050203606A1 (en) * 2004-03-09 2005-09-15 Vancamp Daniel H. Stent system for preventing restenosis
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US20050267569A1 (en) * 2004-03-27 2005-12-01 Gary Barrett Non-invasive detection of in-stent stenosis and drug elution

Also Published As

Publication number Publication date
EP1729788A1 (de) 2006-12-13
US20050233443A1 (en) 2005-10-20
WO2005097147A1 (en) 2005-10-20
US20070219526A1 (en) 2007-09-20
EP1729788B1 (de) 2009-11-25

Similar Documents

Publication Publication Date Title
DE602005017877D1 (de) Restenose-therapie mit mesenchym-stammzellen
DE60319848D1 (de) Medikament mit mesenchym-stammzellen
IS8570A (is) Stoðfrumulaus framhaldsrækt stofnfrumna
GB2441530B (en) Stem Cells
GB2414995B (en) Neural stem cells
DE602005005527D1 (de) Verschlussdüse
EP1809740A4 (de) Herzstammzellen
DE502005006888D1 (de) Implantat mit einstückigem Drehgelenk
ATE523154T1 (de) Marknagel mit formgedächtniselementen
NO20053298D0 (no) Undersjoisk kraftforsyning.
ATE540655T1 (de) Windel mit elastischer oberschicht
DE602005002689D1 (de) Luftbefeuchter
DK2341147T3 (da) Præprimitive stribe- og mesendodermceller
ATE525088T1 (de) Kombinationstherapie
DE602005022766D1 (de) Batteriehülle
DE502005004462D1 (de) Flügelglätter
DE602005001838D1 (de) Stromversorgungseinrichtung
DE602005019525D1 (de) Verschlussdüse
DE602005000791D1 (de) Zwischenverbinder
GB0505510D0 (en) Neural stem cells
FI20045190A (fi) Energiantuotantojärjestely
DE602006007939D1 (de) Prothese mit Spiralstent
DE502004003033D1 (de) Energieführungskette
ES1058102Y (es) Lentilla terapeutica.
FR2876232B3 (fr) Convertisseur-thermo-electrique solaire

Legal Events

Date Code Title Description
8364 No opposition during term of opposition